Results 101 to 110 of about 113,618,068 (200)

Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32. [PDF]

JNCI Cancer Spectr
Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Ligibel J, Stos PM, Shepherd LE, Parulekar WR, Stambolic V.   +9 more
europepmc   +1 more source

Imaging Pitfalls in Evaluating Liver Metastases in Breast Cancer With Autosomal Dominant Polycystic Kidney Disease-Associated Polycystic Liver: A Case Report. [PDF]

Clin Case Rep
Aso S, Sasaki R, Kawano H, Onagi H, Saeki H, Okazaki M, Ijima K, Kutomi G.   +7 more
europepmc   +1 more source

Salivary Transmembrane Mucins of the MUC1 Family (CA 15-3, CA 27.29, MCA) in Breast Cancer: The Effect of Human Epidermal Growth Factor Receptor 2 (HER2)

The MUC1 family of transmembrane glycoproteins (CA 15-3, CA 27.29, MCA) is aberrantly expressed among patients with breast cancer. Objectives: to measure the level of degradation products of MUC1, including CA 15-3, CA 27.29, and MCA, in the saliva of ...
Lyudmila V. Bel’skaya, Elena I. Dyachenko   +1 more
core   +1 more source

Associations of Multiple Serum Tumor Markers with Radiological Response and Overall Survival in Patients with Advanced Gastric Cancer Receiving First-Line Palliative Systemic Therapy. [PDF]

J Clin Med
Kim H, Jang I, Lee SK, Jo MK, Kim J, Lee JS, Kim Y, Lee J, Kim DH, Yun HY, Han HS.   +10 more
europepmc   +1 more source

Impact of SLCO1B3 767G>C (rs60140950) polymorphism on paclitaxel response in Iraqi women with breast cancer. [PDF]

J Taibah Univ Med Sci
Al-Hussein BSJ, Al-Juhaishi AMR, Abo Almaali HMM, Alaskari AAJ.   +3 more
europepmc   +1 more source

Early detection and localization of recurrent prostate cancer using [Formula: see text]F-DCFPyL PET/CT in patients with low and ultra-low PSA levels. [PDF]

EJNMMI Res
Sonni I, Gulpe A, Nickols NG, Schaffer D, Montagut L, Berenji GR, Rettig MB.   +6 more
europepmc   +1 more source

Predictive Modeling for Ovarian Cancer Diagnosis: Integration of Positron Emission Tomography/Computed Tomography (PET/CT) Metabolic Parameters, Clinical Risk Factors, and Serum Biomarkers. [PDF]

Cureus
Almomani SZ, Almasaleha A, Alfshikat M, Al-Smadi AA, Alrawashdeh M, Al Tarawneh B, Al Sabayleh M, Al-Sharaia I.   +7 more
europepmc   +1 more source

Peripheral blasts at apheresis as a risk factor for survival after tisagenlecleucel in children and young adults. [PDF]

Blood Adv
Lyons KU, Miller KR, Deb A, Nicklawsky A, Baggott C, Nguyen K, Prabhu S, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano JA, Moskop A, Keating AK, Baumeister S, Myers GD, Karras NA, Cooper S, Qayed M, Hermiston M, Satwani P, Krupski C, Chinnabhandar V, Mackall CL, John S, Laetsch TW, Curran KJ, Verneris MR, Schultz LM, Fabrizio VA.   +29 more
europepmc   +1 more source

CA 15.3, Metastatic Burden, and Overall Survival in Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer: Real-World Evidence from Peru. [PDF]

Biomedicines
Valencia G, Rioja P, Meza J, Saavedra A, Castillo C, Sánchez A, Mantilla R, Bravo J, Gomez HL, Heredia M, Peralta O, Chirito M, Rabanal C, Aliaga K, Morante Z, Muñante B, Fuentes H, Munive C, Castañeda C, Neciosup S, Vidaurre T.   +20 more
europepmc   +1 more source

Large language model-guided CAR-T in silico platform for cytokine optimization in liver cancer with low antigen density. [PDF]

J Hematol Oncol
Nan H, Shen X, Yang Y, Wang S, Li YR.
europepmc   +1 more source